Young Investigator Research Grant
Applications will be accepted from 12/17/2024 - 02/28/2025.
Goals:
- To foster research within the SPP by providing funds to young investigators in the field of pediatric pathology.
- To fund a pilot project which will lead to long-term research support from other granting agencies.
Use of Funds:
The funds are to be used to facilitate basic or applied research by a young investigator in the field of pediatric and perinatal pathology. Research into any aspect of pediatric disease will be considered, including morphological, biochemical, behavioral, physiological, genetic, and epidemiological studies. Appropriate expenditures include capital equipment, reagents and supplies, research-related travel, salary supplementation, service costs (e.g., electron microscopy, histology), and animal care costs. Indirect costs are not allowed.
Eligibility:
Applicants must meet ALL of the following criteria:
- Hold a doctoral degree (MD, DO, DDS, DVM, or equivalent; PhD, DPhil, or equivalent);
- Be a resident or fellow, full-time, in an accredited pathology training program, OR be a post-doctoral fellow working in the laboratory of a faculty/staff person in pediatric pathology, OR be a faculty/staff person in pediatric pathology practicing in his or her first academic appointment at the level of instructor or assistant professor for 7 years or less;
- Be a member of the SPP OR be sponsored by a member of the SPP.
Amount of Award:
A single annual award of $35,000 will be made.
Selection Process:
Complete applications must be received by the Research & Awards Committee Chair no later than Friday, February 28, 2025. The SPP Research & Awards Committee will review all applications, and funding decisions will be announced by early April 2025. Consideration will be given to scientific merit and the background and career goals of the applicant. The award will be funded July 1, 2025.
Application Instructions:
All portions of the application must be completed. Incomplete applications will not be considered. Although Institutional Review Board (for human studies) or Animal Care Committee (for animal studies) approval will be required before the award is funded, such approval can be deferred until after an initial funding decision has been made.
A complete application includes ALL of the following:
- Cover Sheet (Please click to download: MS Word | PDF )
- Research Proposal (limited to 5 pages, excluding references), to include:
- Specific aims
- Background and significance
- Preliminary data, if available (not required)
- Research design and methods
- Itemized budget (limited to 1 page)
- Applicant's biosketch (NIH format)
- Personal Statement (limited to 1 page) - The applicant should indicate how the proposed research project fits with his/her personal career goals
- Sponsor's letter of support (if applicant is not an SPP member)
- Letter of support from Chairperson or appropriate institutional representative which should indicate that adequate resources are available at the applicant's institution to support the proposed project and the salary support that will be provided for the applicant.
Applications should be e-mailed as a single PDF to Ben Wilkins (SPP R&A committee chair) at [email protected]. Questions may also be directed to Dr. Wilkins at the same address.
Deadline: February 28, 2025, at 11:59 pm PT.
Young Investigator Grant Winners
Year |
# |
Name |
Institution |
Research Project |
Links |
1997 |
NA |
(Not awarded) |
|
|
n/a
|
1998 |
NA |
Russell Broaddus, MD, PhD
|
Baylor |
Specific cytokine-directed immunotherapy in a mouse model of inflammatory bowel disease |
n/a |
1999 |
10 |
Hector Melin-Aldana |
NA |
Molecular control of the regenerative response of the developing liver |
n/a |
2000 |
NA |
Monique DePaepe |
NA |
Fas/Fas ligand in the pathogenesis of bronchopulmonary dysplasia |
n/a |
2001 |
4 |
Michael Fritsch |
University of Wisconsin |
The role of histone acetylation in regulating embryonic stem cell differentiation |
n/a |
2002 |
NA |
(Not awarded) |
|
|
n/a |
2003 |
7 |
Roberto Gianini |
NA |
Transgenic expression of surviving in NOD mouse islets |
n/a |
2004 |
NA |
Rene L. Galindo, MD, PhD |
UT Southwestern |
Molecular Pathogenesis of Alveolar Rhabdomyosarcoma |
n/a |
2005 |
NA |
Maureen O’Sullivan, MD
|
BC Children's Hospital |
Role of MLL4 in Sarcomagenesis |
n/a |
2006 |
NA |
Jason Jarzembowski, MD, PhD
|
University of Michigan |
Genomic and proteomic heterogeneity of neuroballistic tumor component cell types |
n/a |
2007 |
7 |
Scott Boyd |
Stanford |
Prognostic significance and biological roles of microRNAs in pediatric acute lymphoblastic leukemia |
n/a |
2008 |
6 |
Christopher Pearson |
Nationwide Children's Hospital
|
The Identification of Myotubularin Interacting Proteins Provides Insight Into the Pathogenesis of X-linked Myotubular Myopathy |
n/a |
2009 |
8 |
Kathryn Wikenheiser-Brokamp, PhD
|
Cincinnati Children's Hospital |
Role of DICER1 in the Pathogenesis of Pleuropulmonary Blastoma |
n/a |
2010 |
7 |
Kyle Kurek, MD, PhD
|
Children's Hospital of Boston |
Metachondromatosis |
n/a |
2011 |
NA |
Dinesh Rakheja, MD, PhD
|
Children's Hospital of Dallas |
PTPE and Wilms tumorigenesis |
n/a |
2012 |
NA |
Angshumoy Roy, MD, PhD
|
Baylor |
Defining the role of MDM4 gene amplification and overexpression in hepatoblastoma |
n/a |
2013 |
6 |
Gabrielle Rizzuto, MD, PhD
|
UCSF |
Immune response to infection at the maternal-fetal interface |
https://journals.asm.org/doi/10.1128/IAI.00153-17 https://journals.asm.org/doi/10.1128/IAI.00625-16
|
2014 |
6 |
Nikolina Dioufa, MD, MSc
|
Harvard |
An anchorage independent growth system as a model to study the molecular pathways that lead to drug resistance and metastasis in Ewing Sarcoma |
n/a |
2015 |
9 |
Jeff Terry, MD, PhD |
BC Children's |
Identification of bacteria by in situ molecular visualization in pediatric Crohn's disease |
Not published yet. |
2016 |
6 |
Elena Repnikova, PhD
|
Children's Mercy Hospital, Kansas City |
Characterization of copy number variations in genomic regions containing long non-coding RNA using DNA microarray |
n/a |
2017 |
10 |
Shengmei Zhou, MD
|
Children's Hospital of Los Angeles |
Integrated Genomic Analysis of High Risk Hepatoblastoma
|
Not published yet.
|
2018 |
9 |
Gabrielle Rizzuto, MD, PhD |
UCSF |
Profiling the maternal T cell response to placental antigen |
https://www.nature.com/articles/s41586-022-04471-0 https://rupress.org/jem/article/219/5/e20211515/213136/Trophoblast-antigens-fetal-blood-cell-antigens-and
|
2019 |
|
Jessica Saunders, MD |
Seattle Children's Hospital
|
Luminex-based diagnosis of Hirschsprung disease |
n/a |
2020 |
|
Jennifer Pogoriler, MD, PhD |
Children's Hospital of Philadelphia |
Molecular Evaluation of Mucinous Cell Clusters in Congenital Pulmonary Airway Malformations to Determine Clonality and Relationship to Adult Mucinous Tumors
|
https://www.nature.com/articles/s41379-022-01129-0
|
2021 |
|
Jonathan Bush, MD, FRCPC |
BC Children's & Women's Hospital and Health Centre, Vancouver, Canada |
High-Resolution Mass Spectrometry Proteomic Analysis in Osteosarcoma |
Not published yet. |
2022 |
|
Serena Tan, MD |
Stanford University School of Medicine, Stanford, CA |
Characterizing the cellular context of liver vascular lesions |
Not published yet. |
2023 |
|
Sabrina Salberg, PhD
|
Monash University
|
Developing a Preclinical Model of Neonatal Inflicted Head Trauma to Improve Outcomes for Survivors |
Not published yet. |
2024 |
|
Virginia Chu Cheung, PhD
|
University of California, San Diego |
Examining the cellular dynamics of the human implantation site using pluripotent stem cells |
N/A |
|